Press releaseBusiness Wire
Genetix Biotherapeutics
BLUE · NASDAQ
Price unavailable right now.
No price history for this range.
Latest news
- Press releaseBusiness Wire
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
- Press releaseBusiness Wire
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
- News
Carlyle And SK Capital Amend Agreement To Acquire bluebird bio, Update Tender Offer Instructions For Stockholders
- Press releaseBusiness Wire
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
- NewsVandana Singh
Bluebird Bio Shareholders Get New All-Cash Offer From Private Equity
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseBusiness Wire
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
- Press releaseBusiness Wire
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
- News
bluebird bio, Carlyle, SK Capital And Beacon Parent Holdings Receive All Required Regulatory Approvals To Complete bluebird Acquisition
- Press releaseBusiness Wire
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
- Press releaseBusiness Wire
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
- NewsAnthony Noto
Deal Dispatch: US M&A Is Quiet, But Abroad? Volume Is Spiking
- NewsVaishali Prayag
BlueBird Shares Are Up Today: What's Going On?
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- News
Market-Moving News for March 31st
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseBusiness Wire
bluebird bio Confirms Receipt of an Unsolicited Non-Binding Proposal from Ayrmid
- News
'Bluebird Gets New M&A Bid, Seeking To Top Private Equity Offer' - Endpoints News
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
- Press releaseBusiness Wire
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
- NewsVandana Singh
Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CMRX, WBA, BLUE on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WBA, IVAC, BLUE on Behalf of Shareholders
- Press releasePRNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of bluebird bio, inc. - BLUE
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, HUSA, BLUE on Behalf of Shareholders
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders
- Press releaseBusiness Wire
BLUEBIRD BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of bluebird bio, Inc. - BLUE
- Press releasePRNewswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc.
- NewsAvi Kapoor
Dow Tumbles Over 700 Points; US Services PMI Falls In February
- Press releasePRNewswire
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of bluebird bio, Inc. - BLUE
- Press releasePRNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BLUE, VOXX, CARA, CYTH on Behalf of Shareholders
- Press releaseBusiness Wire
Shareholder Alert: Ademi LLP investigates whether bluebird bio, Inc. is obtaining a Fair Price for its Public Shareholders
- NewsAvi Kapoor
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket
- News
Earnings Scheduled For November 14, 2024
- News
Exploring bluebird bio's Earnings Expectations
- News
The Analyst Verdict: bluebird bio In The Eyes Of 5 Experts
- News
What 4 Analyst Ratings Have To Say About bluebird bio
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.